Panel 1:
Panel 1:
Panel 2:
Panel 2:
Panel 3:
Panel 3:
Panel 4:
Panel 4:
Panel 5:
Panel 5:
FOR SENSITIVE OR
IRRITATED EYE CONTOUR
SENSITIVE OR IRRITATED EYE CONTOUR SUBJECT TO REDNESS, STINGING, PUFFINESS, OR SENSATIONS OF DISCOMFORT. SUITABLE FOR CONTACT LENS WEARERS.

TOLERIANE ULTRA EYE CONTOUR is an intense dermatological moisturiser. Anti-discomfort. Anti-puffiness. Tested on allergic skin.

HOW TO APPLY
Apply gently to the eye contour area every morning and evening without rubbing, according to the technique described below:

  1. Apply a small amount of product to the tip of your ring finger
  2. Delicately dab over the eye contour area and eyelids
  3. Apply gentle pressure from the inside of the eye outwards
  4. Finish by applying light pressure over the whole eye
Ultra-light and fresh texture.
With La Roche-Posay Thermal Spring Water.
Moisturizing and ultra-soothing skincare associating Neurosensine + Niacinamide complex to target puffiness and discomfort on the eye contour with soothing and protective La Roche-Posay Thermal Spring Water. 
Intensively and lastingly soothes the ultra-sensitive eye contour.
Ultra-hermetic packaging, anti-contamination, anti-oxidation, anti-dried-up-residue and anti-waste, allowing for a highly minimalist formulation and optimal tolerance.
0% fragrance/alcohol.
Tested under dermatological control on allergic skin. Tested under ophtalmological control. Non-comedogenic.

Validity after opening:
12 Months
  • Pump
  • Adults
  • Intense soothing
    Anti-puffiness
    24hr hydration 
  • Eye contour

KEY INGREDIENTS
LET'S TAKE A LOOK INSIDE

NEUROSENSINE

Decreases discomfort. Significantly reduces skin reactivity and sensitivity.

NIACINAMIDE

Soothing active ingredient. It reduces itching sensations. Suitable for allergy prone skin.

LA ROCHE-POSAY THERMAL SPRING WATER

Calms and reduces skin irritations.
AQUA/WATER • GLYCERIN • SQUALANE • PROPANEDIOL • BUTYLENE GLYCOL • BUTYROSPERMUM PARKII BUTTER / SHEA BUTTER • PENTYLENE GLYCOL • NIACINAMIDE • DIMETHICONE • POLYMETHYLSILSESQUIOXANE • POLYSORBATE 20 • GLYCERYL ACRYLATE / ACRYLIC ACID COPOLYMER • DIMETHICONOL • ALUMINUMSTARCHOCTENYLSUCCINATE • AMMONIUM POLYACRYLDIMETHYLTAURAMIDE / AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • DISODIUMEDTA • CITRIC ACID • ACETYL DIPEPTIDE-1 CETYL ESTER

B166593/1

IT'S PROVEN

Bar
TEST RESULTS AFTER 4 WEEKS

Reduction of signs of skin reactivity and discomfort**
- 68% stinging sensations
- 100% heating/burning sensations
- 90% tightness
- 90% prickling sensations

**In vivo clinical scoring by dermatologist, n=46 women with sensitive skin, 4 weeks, 2 applications/day morning and evening

percentage sign with the number 90 inside, in blue
Reduction of undereye bags***
"The product leaves the eye contour skin soothed" for 90% of women.
"The eye contour skin looks softer after the 1st application" for 90% of women.
"The eye contour skin looks more supple" for 88% of women.

***Cosmetoclinical trial under dermatological control, self-assessment questionnaire on eye puffiness, n=51 women with sensitive eye contour, 2 applications/day morning and evening

EXPERT
QUOTE

Wash your hands if you have been in contact with an allergen before applying a cream or touching your face. Try to avoid rubbing your eyes.

Sitecore CDO

THE PERFECT MATCH
FOR YOUR SKIN

THE TOLERIANE WINNING TRIO

TOLERIANE is a range of products designed to hydrate, soothe and protect sensitive to allergy-prone skin.
ALLERGIC OR ULTRA-SENSITIVE SKIN

TOLERIANE ULTRA EYE CONTOUR is an intense dermatological moisturiser. Anti-disco...

Check it out
TOLERIANE ULTRA CREAM is an intense dermatological moisturiser. It soothes and r...
Check it out

DISCOVER THE OTHER
PRODUCTS OF THE RANGE

TOLERIANE is a range of products designed to hydrate, soothe and protect sensitive to allergy-prone skin.
Question mark icon

Did you
know?

woman holding a jar of La Roche-Posay Cicaplast Baume B5, with a blue background

If not correctly treated, sensitive skin is 2 to 5 times more likely to develop medically diagnosed skin allergies*.

* Source: FARAGE 2008 British Association of Dermatologists. British Journal of Dermatology 2008 159, pp231–266